BridgeBio Pharma News

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil

Mar 14 16:05 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C

Mar 14 16:05 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Scott Randal W.

Mar 5 16:05 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil

Feb 21 22:41 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director HOMCY CHARLES J

Feb 21 16:07 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C

Feb 21 16:07 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah

Feb 20 16:04 ET

BridgeBio Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-NEIL KUMAR(5.59%)

Feb 16 19:17 ET

BridgeBio Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.36%)

Feb 13 18:11 ET

BridgeBio Pharma | 5: Annual statement of changes in beneficial ownership of securities-Director Valantine Hannah

Feb 13 16:07 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah

Feb 13 16:02 ET

BridgeBio Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.8%)

Jan 29 17:29 ET

BridgeBio Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(2.92%)

Jan 23 00:00 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah

Jan 18 00:00 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director MCCORMICK FRANK

Dec 28, 2023 00:00 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Scott Randal W.

Dec 20, 2023 16:00 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah

Dec 19, 2023 16:00 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Scott Randal W.

Dec 5, 2023 16:00 ET

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(15.7%),O. Andreas Halvorsen(15.7%), etc.

Nov 22, 2023 16:15 ET

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C

Nov 20, 2023 16:00 ET